Dogwood Therapeutics (DWTX) Stock Price, News & Analysis

Company Overview

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Key Stats

• Today's Range: $3.44 to $4.22
• 50-Day Range: $2.94 to $11.13
• 52-Week Range: $1.62 to $29.28
• Volume: 702,987 shs
• Average Volume: 1.91 million shs
• Market Capitalization: $4.97 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DWTX Stock Analysis - Frequently Asked Questions

How have DWTX shares performed this year?

Dogwood Therapeutics' stock was trading at $2.49 at the start of the year. Since then, DWTX stock has increased by 49.8% and is now trading at $3.73.
View the best growth stocks for 2025 here.

How were Dogwood Therapeutics' earnings last quarter?

Dogwood Therapeutics, Inc. (NASDAQ:DWTX) released its quarterly earnings results on Monday, March, 31st. The company reported ($6.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.49) by $4.80.

When did Dogwood Therapeutics' stock split?

Dogwood Therapeutics shares reverse split on the morning of Wednesday, October 9th 2024. The 1-25 reverse split was announced on Saturday, January 1st 2000. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, October 8th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of Dogwood Therapeutics?

Shares of DWTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 3/31/2025
• Today: 4/16/2025
• Next Earnings (Estimated): 5/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:DWTX
• CIK: 1818844
• Web: www.dwtx.com
• Phone: (866) 620-8655
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($11.34)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-5,300,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -217.12%
• Return on Assets: -172.06%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.71
• Quick Ratio: 1.71

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.94 per share
• Price / Book: 0.77

Miscellaneous

• Outstanding Shares: 1,332,000
• Free Float: 1,169,000
• Market Cap: $5.06 million
• Optionable: N/A
• Beta: 1.99